ABSENCE OF NEUTRALIZING ANTIBODY FORMATION DURING INCOBOTULINUMTOXINA TREATMENT OF SPASTICITY IN BOTULINUM TOXIN-NAIVE CHILDREN WITH CEREBRAL PALSY: POOLED ANALYSIS OF THREE PHASE 3 STUDIES

被引：0
|
作者：
Chambers, Henry G. [1 ]
Kanovsky, Petr [2 ,3 ]
Schroeder, A. Sebastian [4 ,5 ]
Dabrowski, Edward [6 ]
Geister, Thorin L. [7 ]
Dersch, Hanna [7 ]
Pulte, Irena [7 ]
Althaus, Michael [7 ]
Banach, Marta [8 ]
Gaebler-Spira, Deborah [9 ]
Heinen, Florian [4 ,5 ]
机构：
[1] Rady Childrens Hosp, San Diego, CA USA
[2] Palacky Univ Olomouc, Fac Med & Dent, Olomouc, Czech Republic
[3] Palacky Univ Olomouc, Univ Hosp, Olomouc, Czech Republic
[4] Ludwig Maximilian Univ Munich, Dr Hauner Childrens Hosp, Div Paediat Neurol & Dev Med, Munich, Germany
[5] Ludwig Maximilian Univ Munich, Dr Hauner Childrens Hosp, LMU Ctr Children Med Complex, Munich, Germany
[6] Beaumont Pediat Phys Med & Rehabil Royal Oak, Royal Oak, MI USA
[7] Merz Pharmaceut GmbH, Frankfurt, Germany
[8] Jagiellonian Univ Med Coll, Dept Neurol, Krakow, Poland
[9] Northwestern Feinberg Sch Med, Shirley Ryan AbilityLab, Chicago, IL USA
来源：
TOXICON | 2021年 / 190卷
关键词：
Adolescents; Antibodies; Cerebral palsy; Children; IncobotulinumtoxinA;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 12 条
  • [1] Absence of neutralizing antibody formation during incobotulinumtoxinA treatment of spasticity in botulinum toxin-naive children with cerebral palsy: pooled analysis of Phase 3 studies
    Chambers, H.
    Kanovsky, P.
    Schroeder, A.
    Dabrowski, E.
    Geister, T.
    Hanschmann, A.
    Pulte, I.
    Althaus, M.
    Banach, M.
    Gaebler-Spira, D.
    Heinen, F.
    MOVEMENT DISORDERS, 2021, 36 : S29 - S30
  • [2] Improvement of spasticity-related pain with incobotulinumtoxinA treatment in children/adolescents with cerebral palsy: pooled analysis of Phase 3 studies
    Heinen, F.
    Kanovsky, P.
    Schroeder, A.
    Chambers, H.
    Dabrowski, E.
    Geister, T.
    Hanschmann, A.
    Pulte, I.
    Althaus, M.
    Banach, M.
    Gaebler-Spira, D.
    MOVEMENT DISORDERS, 2021, 36 : S33 - S34
  • [3] IMPROVEMENT OF SPASTICITY-RELATED PAIN WITH INCOBOTULINUMTOXINA TREATMENT IN CHILDREN/ADOLESCENTS WITH CEREBRAL PALSY: POOLED ANALYSIS OF 3 PHASE 3 STUDIES
    Heinen, Florian
    Kanovsky, Petr
    Schroeder, A. Sebastian
    Chambers, Henry G.
    Dabrowski, Edward
    Geister, Thorin L.
    Dersch, Hanna
    Pulte, Irena
    Althaus, Michael
    Banach, Marta
    Gaebler-Spira, Deborah
    TOXICON, 2021, 190 : S31 - S32
  • [4] SAFETY OF INCOBOTULINUMTOXINA IN MULTIPATTERN TREATMENT OF UPPER- AND LOWER-LIMB SPASTICITY IN CHILDREN/ADOLESCENTS WITH CEREBRAL PALSY: POOLED ANALYSIS OF 3 LARGE PHASE 3 STUDIES
    Banach, Marta
    Kanovsky, Petr
    Schroeder, A. Sebastian
    Chambers, Henry G.
    Dabrowski, Edward
    Geister, Thorin L.
    Dersch, Hanna
    Pulte, Irena
    Althaus, Michael
    Gaebler-Spira, Deborah
    Heinen, Florian
    TOXICON, 2021, 190 : S7 - S7
  • [5] LONG-TERM SAFETY AND EFFICACY OF INCOBOTULINUMTOXINA FOR THE TREATMENT OF BLEPHAROSPASM IN BOTULINUM TOXIN-NAIVE SUBJECTS: RESULTS OF A PHASE 3 STUDY
    Mitsikostas, Dimos D.
    Dekundy, Andrzej
    Sternberg, Kati
    Althaus, Michael
    Pagan, Fernando
    TOXICON, 2018, 156 : S81 - S82
  • [6] IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study
    Heinen, Florian
    Kanovsky, Petr
    Schroeder, A. Sebastian
    Chambers, Henry G.
    Dabrowski, Edward
    Geister, Thorin L.
    Hanschmann, Angelika
    Martinez-Torres, Francisco J.
    Pulte, Irena
    Banach, Marta
    Gaebler-Spira, Deborah
    JOURNAL OF PEDIATRIC REHABILITATION MEDICINE, 2021, 14 (02) : 183 - 197
  • [7] Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: A pooled-data analysis of three clinical trials
    Yablon, Stuart A.
    Brashear, Allison
    Gordon, Mark F.
    Elovic, Elie P.
    Turkel, Catherine C.
    Daggett, Simon
    Liu, Jingyu
    Brin, Mitchell F.
    CLINICAL THERAPEUTICS, 2007, 29 (04) : 683 - 690
  • [8] POOLED EFFICACY ANALYSIS OF INCOBOTULINUMTOXINA IN THE MULTIPATTERN TREATMENT OF UPPER- AND LOWER-LIMB SPASTICITY IN CHILDREN AND ADOLESCENTS WITH CEREBRAL PALSY
    Heinen, Florian
    Kanovsky, Petr
    Schroeder, A. Sebastian
    Chambers, Henry G.
    Dabrowski, Edward
    Geister, Thorin L.
    Dersch, Hanna
    Pulte, Irena
    Althaus, Michael
    Banach, Marta
    Gaebler-Spira, Deborah
    TOXICON, 2021, 190 : S32 - S33
  • [9] BOTULINUM TOXIN TYPE A FOR THE TREATMENT OF FOCAL SPASTICITY IN CHILDREN WITH CEREBRAL PALSY IN THAILAND: A COST-UTILITY ANALYSIS
    Prawjaeng, J.
    Hadnorntun, P.
    Leelahavarong, P.
    Ploypetch, T.
    Chueluecha, C.
    Jintakul, N.
    Wathanadilokul, U.
    Lomaninoparat, R.
    Srinonprasert, V
    Kumthornthip, W.
    VALUE IN HEALTH, 2023, 26 (12) : S147 - S147
  • [10] POOLED EFFICACY AND SAFETY ANALYSIS OF INCOBOTULINUMTOXINA IN THE TREATMENT OF UPPER- AND LOWER-LIMB SPASTICITY IN CHILDREN WITH SEVERE CEREBRAL PALSY (GMFCS LEVELS IV AND V)
    Kanovsky, Petr
    Gaebler-Spira, Deborah
    Schroeder, A. Sebastian
    Chambers, Henry G.
    Dabrowski, Edward
    Geister, Thorin L.
    Dersch, Hanna
    Pulte, Irena
    Althaus, Michael
    Banach, Marta
    Heinen, Florian
    TOXICON, 2021, 190 : S36 - S37
12